• Search
  • Login
  • Register
Menu
  • BJH
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Clinical practice

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19

Clinical practice

High-frequency vincristine-steroid pulses do not benefit outcomes in acute lymphoblastic leuka...

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • Highlights in chronic lymphocytic leukaemia
  • Highlights in chronic myeloid leukaemia
  • Highlights in lymphoma
  • Long-term outcomes of isatuximab in high-risk multiple myeloma
  • Highlights in multiple myeloma
  • Navigating secondary acute myeloid leukaemia in 2023
  • Highlights in acute myeloid leukaemia and myelodysplastic syndromes
  • Highlights in acute lymphoblastic leukaemia
  • New haematology reimbursements in Belgium
Clinical practice

Clinical efficacy of non-pharmacological therapy for sickle cell disease and oncologic conditi...

Read more
Clinical practice

Anaemia as a mediator of adverse pregnancy outcomes in sickle cell disease

Read more
Clinical practice

A new and efficient treatment regimen for patients undergoing allogeneic HSCT

Read more
Clinical practice

Safety data of lisocabtagene maraleucel supports its use in an outpatient setting

Read more
Clinical practice

Favorable clinical outcomes in patients with refractory or relapsed CLL/SLL

Read more
Clinical practice

Clinical study recommends against using antithrombotic therapy in ill outpatients with COVID-1...

Read more
Clinical practice

Long-term remission rates after treatment with tisagenlecleucel in paediatric and young adult ...

Read more
Clinical practice

Fixed-duration venetoclax-rituximab outperforms bendamustine-rituximab in patients with R/R CL...

Read more
1 2 3 4 5 6 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2023